MEKing Retinoids Work Better

Retinoids can induce terminal differentiation in a subset of neuronal cancer cells, but what determines response has been unclear. In a recent issue of Cell, Hِlzel and colleagues show that hyperactive RAS signaling imparts retinoid resistance to neuroblastoma cells, which can be reversed by inhibiting MAPK, suggesting new therapeutic opportunities.